Literature DB >> 9556594

Regulatory interactions between the human HOXB1, HOXB2, and HOXB3 proteins and the upstream sequence of the Otx2 gene in embryonal carcinoma cells.

S Guazzi1, M L Pintonello, A Viganò, E Boncinelli.   

Abstract

Vertebrate Hox and Otx genes encode homeodomain-containing transcription factors thought to transduce positional information along the body axis in the segmental portion of the trunk and in the rostral brain, respectively. Moreover, Hox and Otx2 genes show a complementary spatial regulation during embryogenesis. In this report, we show that a 1821-base pair (bp) upstream DNA fragment of the Otx2 gene is positively regulated by co-transfection with expression vectors for the human HOXB1, HOXB2, and HOXB3 proteins in an embryonal carcinoma cell line (NT2/D1) and that a shorter fragment of only 534 bp is able to drive this regulation. We also identified the HOXB1, HOXB2, and HOXB3 DNA-binding region on the 534-bp Otx2 genomic fragment using nuclear extracts from Hox-transfected COS cells and 12.5 days postcoitum mouse embryos or HOXB3 homeodomain-containing bacterial extracts. HOXB1, HOXB3, and nuclear extracts from 12.5 days postcoitum mouse embryos bind to a sequence containing two palindromic TAATTA sites, which bear four copies of the ATTA core sequence, a common feature of most HOM-C/HOX binding sites. HOXB2 protected an adjacent site containing a direct repeat of an ACTT sequence, quite divergent from the ATTA consensus. The region bound by the three homeoproteins is strikingly conserved through evolution and necessary (at least for HOXB1 and HOXB3) to mediate the up-regulation of the Otx2 transcription. Taken together, our data support the hypothesis that anteriorly expressed Hox genes might play a role in the refinement of the Otx2 early expression boundaries in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556594     DOI: 10.1074/jbc.273.18.11092

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis.

Authors:  Elizabeth Eklund
Journal:  Crit Rev Oncog       Date:  2011

2.  CDP is a repressor of mouse mammary tumor virus expression in the mammary gland.

Authors:  Q Zhu; K Gregg; M Lozano; J Liu; J P Dudley
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 3.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Non-homeodomain regions of Hox proteins mediate activation versus repression of Six2 via a single enhancer site in vivo.

Authors:  Alisha R Yallowitz; Ke-Qin Gong; Ilea T Swinehart; Lisa T Nelson; Deneen M Wellik
Journal:  Dev Biol       Date:  2009-08-28       Impact factor: 3.582

5.  Mouse transgenesis identifies conserved functional enhancers and cis-regulatory motif in the vertebrate LIM homeobox gene Lhx2 locus.

Authors:  Alison P Lee; Sydney Brenner; Byrappa Venkatesh
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

6.  A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.

Authors:  Laixi Bi; Bin Zhou; Haiying Li; Licai He; Chunjing Wang; Zhonggai Wang; Liqing Zhu; Mengqian Chen; Shenmeng Gao
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

7.  The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1.

Authors:  Fenghe Cui; Qian Zhou; Kuang Xiao; Shengwei Ma
Journal:  Yonsei Med J       Date:  2020-03       Impact factor: 2.759

8.  Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites.

Authors:  Michelle M Thiaville; Alexander Stoeck; Li Chen; Ren-Chin Wu; Luca Magnani; Jessica Oidtman; Ie-Ming Shih; Mathieu Lupien; Tian-Li Wang
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.